Xanadu Quantum Technologies Inc. ("Xanadu"), a leading photonic quantum computing company, today is hosting its 2026 Analyst Day at the Nasdaq MarketSite in New York, in advance of the anticipated ...
This study presents valuable findings implicating nuclear export in the regulation of protein condensate behaviour and TDP-43 phase behaviour, suggesting a link to pathogenic aggregation in ALS/FTD.
The event was well attended, reflecting strong engagement from the financial community as Xanadu advances toward becoming a publicly listed company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results